We are pointing our method at risk modeling, research, and evidence synthesis for professionals: answers traceable to the data and assumptions behind them. This is decision support, not investment advice. We are looking for a few design partners.
Risk and research tooling a professional can audit, with every figure traceable to its inputs.
Tied to filings, market data, and stated model assumptions, with the source and the math shown.
When the data does not support a conclusion, it returns nothing rather than a confident-looking number.
Every figure traces back to its inputs and assumptions, the way a risk committee expects.
Every figure traces to its inputs, filings, and stated model assumptions, with a confidence estimate. When the data is too thin to support a conclusion, the system returns nothing rather than a confident number.
This field is still in research, but the underlying method is in production today in biotech. Run unsupervised on a real 1,514 × 1,055 E. coli compendium, it recovered the known L-rhamnose regulon (55 of 60 components robust, confirmed against the iML1515 reference) in about two seconds. See it working on the FluxPilot page.
Finance is active research, not a shipped product, and it is decision support, not investment advice. Our one product in production today is in biotech. If this is your field and you want to shape it as an early design partner, tell us below.
Tell us the risk or research workflow. We work with a small number of design partners per field before anything ships.